Rheumatoid Arthritis Clinical Trials in New York

Showing 3041-3060 of 3,596 trials

Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy

NCT00919061

The purpose of this study is to test an investigational combination of drugs for bile duct or gallbladder cancers. Gemcitabine and cisplatin are two forms of chemotherapy commonly used in combination to treat bile duct and gallbladder cancers. We are looking to improve treatment results. We will attempt to do so by adding sorafenib (a type of monoclonal antibody) to your treatment plan. Sorafenib acts by attaching to blocking specific targets on cells. These targets may help the cancer cells grow and divide. This study will help answer the question of whether sorafenib is a helpful drug in patients with bile duct or gallbladder cancers when given with gemcitabine and cisplatin. This study is a phase 2 study. The purpose of a phase 2 study is to find out what effects, good and/or bad, sorafenib in combination with gemcitabine and cisplatin has on advanced bile duct and gallbladder cancers.

Extrahepatic Bile Duct CancerGallbladder Cancer

Memorial Sloan Kettering Cancer Center39 participantsStarted Aug 2009

New York, New York, United States

COMPLETEDPhase 2< 1 mile

Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses

NCT00375739

The purpose of this study is to determine whether topical application of PEP005 is safe for the treatment of actinic keratoses.

Actinic Keratosis

Peplin200 participantsStarted Sep 2006

Huntsville, Alabama, United States • Tucson, Arizona, United States • Hot Springs, Arkansas, United States +21 more locations

Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy

Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses

Rheumatoid Arthritis Trials in Other Cities

Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide in Patients With CNS Tumors

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users

A Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Treatment Naïve Patients With Infantile-Onset Pompe Disease

Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation

Noninvasive Methods to Monitor Graft Survival in Heart Transplant Patients

Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)

Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors

Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer

Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab

Racial and Ethnic Disparities in Acute Pain Control

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months

Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis

Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis

Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

104RA204 Assessment of the Safety and Efficacy of BG9924 in Rheumatoid Arthritis (RA) Participants

Other Conditions in New York